Kirsten B. Goldberg - Dissemin

Language
Login

All papers authored by Kirsten B. Goldberg

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2021 Elaine Chang

ORCID

, Andrea B. Apolo

ORCID

ORCID

, Stephanie Chisolm

ORCID

, Vinay Duddalwar

ORCID

, Jason A. Efstathiou, Kirsten B. Goldberg

ORCID

, Donna E. Hansel

ORCID

, Ashish M. Kamat

ORCID

, Paul G. Kluetz, Seth P. Lerner, Elizabeth Plimack, Tatiana Prowell, Harpreet Singh, Daniel Suzman and 6 other authors

Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Preeti Narayan, Tatiana M. Prowell

ORCID

, Jennifer J. Gao

ORCID

, Laura L. Fernandes

ORCID

, Emily Li

ORCID

, Xiling Jiang, Junshan Qiu, Jianghong Fan, Pengfei Song, Jingyu Yu, Xinyuan Zhang, Bellinda L. King-Kallimanis, Wei Chen, Tiffany K. Ricks, Yutao Gong and 20 other authors

FDA Approval Summary: Alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Preeti Narayan, Sakar Wahby, Jennifer J. Gao

ORCID

, Laleh Amiri-Kordestani, Amna Ibrahim, Erik Bloomquist, Shenghui Tang, Yuan Xu, Jiang Liu, Wentao Fu, Pengfei Song, Bellinda L. King-Kallimanis, Sherry Hou, Yutao Gong, Shyam Kalavar and 9 other authors

FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1

Upload

Missing publications? Search for publications with a matching author name.